Hopewell Therapeutics’ CEO on the company’s $25M raise and next-gen LNPs
- blonca9
- Jun 7, 2023
- 1 min read
Updated: Jun 15, 2023
Lou Brenner discusses his company’s raise today and explains how Hopewell is designing LNPs to go beyond the liver.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.